Evoke Pharma Inc (Nasdaq:EVOK)
Health Care/Life Sciences • Pharmaceuticals
CIK 1403708
Company
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
Address
420 Stevens Avenue
Suite 370
Solana Beach, California 92075-2074
420 Stevens Avenue
Suite 370
Solana Beach, California 92075-2074
Employees
4
4
Stock Info
Close
$0.6790
$0.6790
Day Range
0.6072 - 0.6800
0.6072 - 0.6800
52 Week Range
0.5577 - 3.7000
0.5577 - 3.7000
Average volume
51.05K
51.05K
Short Interest
219.82K (02/15/24)
219.82K (02/15/24)
% of Float Shorted
2.65%
2.65%
Market Cap
$5.64M
$5.64M
Revenue
$2.51M
$2.51M
Net Income
-$8.22M
-$8.22M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director David A Gonyer |
Chairman Cam L Garner MBA |
Independent Director Todd C Brady MD, PhD |
Independent Director Malcolm R Hill PharmD |
Independent Director Kenneth J Widder MD |
Independent Director Vickie W Reed CPA |
SEC filings
Date | Form | Event |
---|---|---|
22 Nov, 2024 | 424B5 | |
15 Nov, 2024 | 3 | |
14 Nov, 2024 | SC 13G/A | |
14 Nov, 2024 | SC 13G/A | |
7 Nov, 2024 | 10-Q | |
7 Nov, 2024 | 8-K | |
6 Nov, 2024 | SC 13D/A | |
29 Oct, 2024 | SC 13G/A | |
28 Oct, 2024 | 8-K | |
22 Oct, 2024 | 3 | |
22 Oct, 2024 | 8-K | |
22 Oct, 2024 | 4 | |
17 Oct, 2024 | 8-K | |
1 Oct, 2024 | SC 13D/A | |
27 Sep, 2024 | 8-K | |
27 Sep, 2024 | 424B3 | |
20 Sep, 2024 | SC 13D | |
6 Sep, 2024 | EFFECT | |
4 Sep, 2024 | CORRESP | |
3 Sep, 2024 | UPLOAD | |
29 Aug, 2024 | S-3 | |
21 Aug, 2024 | EFFECT | |
19 Aug, 2024 | CORRESP | |
16 Aug, 2024 | UPLOAD | |
16 Aug, 2024 | 8-K | |
13 Aug, 2024 | S-3 | |
13 Aug, 2024 | 10-Q | |
13 Aug, 2024 | 8-K | |
8 Aug, 2024 | 4 | |
8 Aug, 2024 | 4 | |
8 Aug, 2024 | 4 | |
1 Aug, 2024 | 8-K | |
20 Jun, 2024 | 8-K | |
7 Jun, 2024 | 8-K | |
30 May, 2024 | 3 | |
28 May, 2024 | 8-K | |
24 May, 2024 | 4 | |
24 May, 2024 | 4 | |
24 May, 2024 | 4 | |
24 May, 2024 | 4 | |
24 May, 2024 | 4 | |
15 May, 2024 | DEFA14A | |
14 May, 2024 | 10-K/A | |
14 May, 2024 | 8-K | |
14 May, 2024 | 8-K | |
14 May, 2024 | ARS/A | |
14 May, 2024 | 10-Q | |
10 Apr, 2024 | DEF 14A | |
10 Apr, 2024 | ARS | |
10 Apr, 2024 | DEFA14A | |
29 Mar, 2024 | PRE 14A | |
25 Mar, 2024 | 8-K | |
25 Mar, 2024 | 424B3 | |
21 Mar, 2024 | 8-K | CEO Change |
18 Mar, 2024 | 8-K | |
15 Mar, 2024 | 424B3 | |
15 Mar, 2024 | POS EX | |
14 Mar, 2024 | 8-K | |
14 Mar, 2024 | 10-K | |
13 Mar, 2024 | SC 13G | |
11 Mar, 2024 | SC 13G | |
23 Feb, 2024 | 8-K | |
20 Feb, 2024 | SC 13G | |
14 Feb, 2024 | 8-K | |
13 Feb, 2024 | SC 13G | |
9 Feb, 2024 | 424B4 | |
9 Feb, 2024 | 8-K | |
8 Feb, 2024 | S-1/A | |
8 Feb, 2024 | EFFECT | |
7 Feb, 2024 | CORRESP | |
7 Feb, 2024 | CORRESP | |
17 Jan, 2024 | CORRESP | |
17 Jan, 2024 | CORRESP | |
16 Jan, 2024 | CORRESP | |
16 Jan, 2024 | CORRESP | |
11 Jan, 2024 | S-1/A | |
11 Jan, 2024 | CORRESP | |
11 Jan, 2024 | CORRESP | |
5 Jan, 2024 | CORRESP | |
5 Jan, 2024 | CORRESP | |
4 Jan, 2024 | S-1/A | |
19 Dec, 2023 | S-1/A | |
15 Dec, 2023 | S-1/A | |
29 Nov, 2023 | 8-K | |
27 Nov, 2023 | 8-K | |
22 Nov, 2023 | 8-K | |
15 Nov, 2023 | UPLOAD | |
9 Nov, 2023 | S-1 | |
9 Nov, 2023 | 10-Q | |
9 Nov, 2023 | 8-K | |
1 Nov, 2023 | 8-K | |
12 Oct, 2023 | 8-K | |
11 Aug, 2023 | S-8 | |
10 Aug, 2023 | 10-Q | |
10 Aug, 2023 | 8-K | |
21 Jul, 2023 | 8-K | |
26 May, 2023 | 8-K | |
18 May, 2023 | CT ORDER | |
15 May, 2023 | 10-Q | |
15 May, 2023 | 8-K | |
11 May, 2023 | 4 | |
11 May, 2023 | 8-K | |
11 May, 2023 | 4 | |
11 May, 2023 | 4 | |
11 May, 2023 | 4 | |
11 May, 2023 | 4 | |
9 May, 2023 | 8-K | |
1 May, 2023 | 8-K | |
20 Apr, 2023 | 8-K | |
6 Apr, 2023 | 8-K | |
29 Mar, 2023 | ARS | |
29 Mar, 2023 | DEFA14A | |
29 Mar, 2023 | DEF 14A | |
23 Mar, 2023 | 8-K | |
21 Mar, 2023 | 10-K | |
21 Mar, 2023 | 8-K | |
17 Mar, 2023 | PRE 14A | |
21 Feb, 2023 | 8-K | |
13 Feb, 2023 | 8-K | CEO Change |
10 Feb, 2023 | 4 | |
10 Feb, 2023 | 4 | |
10 Feb, 2023 | 4 | |
30 Jan, 2023 | 8-K | |
30 Nov, 2022 | 8-K | |
9 Nov, 2022 | 8-K | |
9 Nov, 2022 | 10-Q | |
20 Sep, 2022 | 8-K | |
26 Aug, 2022 | 8-K | |
10 Aug, 2022 | 10-Q | |
10 Aug, 2022 | 8-K | |
8 Jun, 2022 | 8-K | |
23 May, 2022 | 8-K | |
20 May, 2022 | 8-K | |
10 May, 2022 | 10-Q | |
10 May, 2022 | 8-K | |
28 Apr, 2022 | 4 | |
28 Apr, 2022 | 4 | |
28 Apr, 2022 | 8-K | |
28 Apr, 2022 | 4 | |
28 Apr, 2022 | 4 | |
28 Apr, 2022 | 4 | |
26 Apr, 2022 | 424B5 | |
26 Apr, 2022 | 8-K | |
15 Mar, 2022 | DEF 14A | |
15 Mar, 2022 | DEFA14A | |
15 Mar, 2022 | DEFA14A | |
8 Mar, 2022 | 10-K | |
8 Mar, 2022 | 8-K | |
4 Mar, 2022 | PRE 14A | |
24 Feb, 2022 | 8-K | |
17 Feb, 2022 | 8-K | |
4 Feb, 2022 | 4 | |
4 Feb, 2022 | 4 | |
4 Feb, 2022 | 4 | |
2 Feb, 2022 | 8-K | |
4 Jan, 2022 | 8-K | |
30 Dec, 2021 | 8-K | |
10 Nov, 2021 | 8-K | |
10 Nov, 2021 | 10-Q | |
20 Oct, 2021 | 8-K | |
29 Sep, 2021 | 8-K | |
12 Aug, 2021 | 8-K | |
12 Aug, 2021 | 10-Q | |
2 Aug, 2021 | 8-K | |
23 Jul, 2021 | 4 | |
23 Jul, 2021 | 4 | |
23 Jul, 2021 | 4 | |
23 Jul, 2021 | 4 | |
23 Jul, 2021 | 4 | |
14 Jul, 2021 | 8-K | |
29 Jun, 2021 | 8-K | |
15 Jun, 2021 | 8-K | |
8 Jun, 2021 | 8-K | |
2 Jun, 2021 | 8-K | |
17 May, 2021 | 3 | |
17 May, 2021 | 4 | |
14 May, 2021 | 8-K | |
12 May, 2021 | 10-Q | |
12 May, 2021 | 8-K | |
6 May, 2021 | SC 13G | |
6 May, 2021 | 8-K | |
6 Apr, 2021 | 8-K | |
26 Mar, 2021 | DEFA14A | |
26 Mar, 2021 | DEF 14A | |
26 Mar, 2021 | SC 13G/A | |
23 Mar, 2021 | SEC STAFF | |
12 Mar, 2021 | PRE 14A | |
11 Mar, 2021 | 8-K | |
11 Mar, 2021 | 10-K | |
23 Feb, 2021 | SEC STAFF | |
29 Jan, 2021 | 4 | |
29 Jan, 2021 | 4 | |
29 Jan, 2021 | 4 | |
20 Jan, 2021 | SC 13G | |
14 Jan, 2021 | 424B5 | |
14 Jan, 2021 | 8-K | |
13 Jan, 2021 | 424B5 | |
13 Jan, 2021 | 8-K | |
6 Jan, 2021 | EFFECT | |
4 Jan, 2021 | CORRESP | |
28 Dec, 2020 | UPLOAD |
Last update:2024-03-06 12:37:18.667272
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.